These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 2997921)
41. Hepatitis B virus DNA sequences in lymphoid cells from patients with AIDS and AIDS-related complex. Laure F; Zagury D; Saimot AG; Gallo RC; Hahn BH; Brechot C Science; 1985 Aug; 229(4713):561-3. PubMed ID: 2410981 [TBL] [Abstract][Full Text] [Related]
42. Structural and epidemiological features of primate lymphotropic retroviruses. Hunsmann G; Schneider J; Bayer H; Jurkiewicz E; Yamamoto N Princess Takamatsu Symp; 1984; 15():109-18. PubMed ID: 6100632 [TBL] [Abstract][Full Text] [Related]
43. HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Robert-Guroff M; Brown M; Gallo RC Nature; 1985 Jul 4-10; 316(6023):72-4. PubMed ID: 2989707 [TBL] [Abstract][Full Text] [Related]
44. Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Kalyanaraman VS; Cabradilla CD; Getchell JP; Narayanan R; Braff EH; Chermann JC; Barré-Sinoussi F; Montagnier L; Spira TJ; Kaplan J Science; 1984 Jul; 225(4659):321-3. PubMed ID: 6330889 [TBL] [Abstract][Full Text] [Related]
45. Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell line. Getchell JP; Heath JL; Hicks DR; Sporborg C; McGrath CR; Kalyanaraman VS J Clin Microbiol; 1986 Apr; 23(4):737-42. PubMed ID: 2422205 [TBL] [Abstract][Full Text] [Related]
46. Acquired immune deficiency syndrome (AIDS) HTLV III/LAV; the causal agent and modes of transmission. Smithies A Health Bull (Edinb); 1986 Jul; 44(4):234-8. PubMed ID: 3017891 [No Abstract] [Full Text] [Related]
47. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. Yarchoan R; Redfield RR; Broder S J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028 [TBL] [Abstract][Full Text] [Related]
48. [LAV type II: a second retrovirus associated with AIDS in West Africa]. Clavel F; Brun-Vézinet F; Guétard D; Chamaret S; Laurent A; Rouzioux C; Rey M; Katlama C; Rey F; Champelinaud JL C R Acad Sci III; 1986; 302(13):485-8. PubMed ID: 3013382 [TBL] [Abstract][Full Text] [Related]
49. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits. Abb J AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224 [TBL] [Abstract][Full Text] [Related]
50. [AIDS and the current significance of serological studies for the presence of antibodies against LAV/HTLV III]. van Gestel WJ Ned Tijdschr Geneeskd; 1985 Feb; 129(5):233-4. PubMed ID: 2983238 [No Abstract] [Full Text] [Related]
51. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Sarngadharan MG; Popovic M; Bruch L; Schüpbach J; Gallo RC Science; 1984 May; 224(4648):506-8. PubMed ID: 6324345 [TBL] [Abstract][Full Text] [Related]
52. Immunoglobulin subclasses of antibodies to human T-cell leukemia/lymphoma virus I-associated antigens in acquired immune deficiency syndrome and lymphadenopathy syndrome. Goudsmit J; Miedema F; Wijngaarden-du Bois RJ; Roos MT; Schellekens PT; Coutinho RA; van der Noordaa J; Melief CJ J Virol; 1985 Jan; 53(1):287-91. PubMed ID: 2981348 [TBL] [Abstract][Full Text] [Related]
53. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697 [TBL] [Abstract][Full Text] [Related]
54. Introduction of lymphadenopathy associated virus or human T lymphotropic virus (LAV/HTLV-III) into the male homosexual community in Amsterdam. Coutinho RA; Krone WJ; Smit L; Albrecht-van Lent P; van der Noordaa J; Schaesberg W; Goudsmit J Genitourin Med; 1986 Feb; 62(1):38-43. PubMed ID: 3005159 [TBL] [Abstract][Full Text] [Related]
55. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168 [TBL] [Abstract][Full Text] [Related]
56. Loss of envelope antigens of HTLV-III/LAV, a factor in AIDS pathogenesis? Gelderblom HR; Reupke H; Pauli G Lancet; 1985 Nov; 2(8462):1016-7. PubMed ID: 2865493 [No Abstract] [Full Text] [Related]
57. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934 [TBL] [Abstract][Full Text] [Related]
58. [Properties and transmission of the AIDS virus]. Laufs R Hautarzt; 1986 May; 37(5):245-9. PubMed ID: 3015839 [TBL] [Abstract][Full Text] [Related]
59. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Hahn BH; Shaw GM; Taylor ME; Redfield RR; Markham PD; Salahuddin SZ; Wong-Staal F; Gallo RC; Parks ES; Parks WP Science; 1986 Jun; 232(4757):1548-53. PubMed ID: 3012778 [TBL] [Abstract][Full Text] [Related]
60. Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain. Sharer LR; Epstein LG; Cho ES; Joshi VV; Meyenhofer MF; Rankin LF; Petito CK Hum Pathol; 1986 Mar; 17(3):271-84. PubMed ID: 3005158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]